We found six heterozygous variants predicted to alter splicing; two in DNA repair-associated genes (BRCA1 and BAP1) and four in tumor suppressor genes (ARHGEF10L, ELL, MYH9, and NCOR2) (Supplementary Table S3). The gene discussed is ARHGEF10L; the disease is neoplasm.